Kirkland & Ellis advised Cloudbreak Health on the transaction, and Ernst & Young Capital Advisors and Dentons advised Voyce. Cloudbreak Health, a GTCR portfolio company and...
Cloudbreak Health’s Acquisition of Voyce and Rebranding
GTCR’s $627 Million Acquisition of Surmodics
Kirkland & Ellis and Cleary Gottlieb Steen & Hamilton represented GTCR in the transaction, and Faegre Drinker Biddle & Reath represented Surmodics. GTCR, a leading private...
Frazier Healthcare’s Acquisition of RevSpring
Goodwin Procter represented Frazier Healthcare Partners in the transaction, and Kirkland & Ellis advised GTCR and its portfolio company RevSpring, Inc. Frazier Healthcare Partners (“Frazier”) announced...
GTCR’s $180 Million Acquisition of Cloudbreak Health
Kirkland & Ellis is advising GTCR on the transaction. GTCR announced that it has signed a definitive agreement to acquire Cloudbreak Health, LLC (“Cloudbreak”) in a corporate...
Azurity Pharmaceuticals’ Acquisition of Slayback Pharma
White & Case and Wilson Sonsini Goodrich & Rosati advised Azurity Pharmaceuticals, Inc., and Kirkland & Ellis advised Slayback Pharma LLC on the transaction. Azurity Pharmaceuticals,...
GTCR’s Acquisition of Majority Stake in Worldpay
Kirkland & Ellis represents GTCR in the transaction, and Wachtell, Lipton, Rosen & Katz represents FIS. GTCR, a leading private equity firm, announced that it has...
Berkshire Partners’ Growth Investment in Point Broadband
Ropes & Gray advised Berkshire Partners, and Kirkland & Ellis advised Point Broadband. Point Broadband Fiber Holding, LLC announced it will receive a significant growth investment...
GTCR’s Partnership with Steve Powell and Mary Mattes to Form Harpula
Kirkland & Ellis advised GTCR on the deal. GTCR announced its Leaders Strategy™ partnership with Steve Powell and Mary Mattes to form Harpula Health Holdings, LLC...
GTCR’s Majority Investment in Biocoat
Kirkland & Ellis advised GTCR on the deal. GTCR announced its strategic majority investment in Biocoat, Incorporated (Biocoat), a leading medical device contract manufacturing organization. As...
Bain Capital Tech Opportunities’ $200 Million Investment in When I Work
Kirkland & Ellis advised Bain Capital Tech Opportunities, while Orrick, Herrington & Sutcliffe advised When I Work in the transaction. When I Work, a leading SaaS...
Bain Capital Tech Opportunities’ R$450 Million Investment in Bionexo
Kirkland & Ellis represented Bain Capital Tech Opportunities in the transaction. Pinheiro Guimarães advised Bionexo S.A. and selling shareholders. Bain Capital Tech Opportunities finalized its agreement...
Apax Funds’ Acquisition of Infogain
Kirkland & Ellis advised Apax on the deal. Apax (the “Apax Funds”) executed its acquisition of Infogain, a Silicon Valley-based leader in digital transformation and software...